NEUROPLASTOGEN

Dead / Abandoned — Abandoned — express abandonment (as of 05 Jun 2020)

What this means for you

This application is over — abandoned 04 Jun 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
88378640
Mark type
Stylized text
Filed
09 Apr 2019
Abandoned
04 Jun 2020
Attorney of record
Kathryn E. Smith

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of worms in pets; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical products and preparations for chloasma; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; Anti-epileptic pharmaceutical preparations; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Ferments for pharmaceutical purposes; Flaxseed for pharmaceutical purposes; Ocular pharmaceuticals; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Turpentine for pharmaceutical purposes, with all of the foregoing in compliance with the Controlled Substances Act and the Food Drug and Cosmetic Act

Owner

Prosecution history

  • 05 Jun 2020 — ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
  • 05 Jun 2020 — ABANDONMENT - EXPRESS MAILED
  • 04 Jun 2020 — TEAS EXPRESS ABANDONMENT RECEIVED
  • 02 Jun 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 02 Jun 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 02 Jun 2020 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
  • 02 Jun 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 02 Jun 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 02 Jun 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 23 Dec 2019 — NOTIFICATION OF FINAL REFUSAL EMAILED
  • 23 Dec 2019 — FINAL REFUSAL E-MAILED
  • 23 Dec 2019 — FINAL REFUSAL WRITTEN
  • 18 Dec 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 18 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 18 Dec 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED

View this trademark record on Marksy